In the elderly mitral regurgitation is very frequent and surgical correction of mitral regurgitation (MR) has often a high operative risk, consequently, over the years, different percutaneous transcatheter techniques have been developed as a valid alternative to surgery. The edge-to-edge repair with the MitraClip device has gained a wide clinical application, supported by several studies, both randomize trials and registries. It is indicated in functional MR as in degenerative MR. The outcome is usually positive, resulting in a reduction of the regurgitation to grade 1+ or 2+ and an improvement in the functional class to I or II reducing hospitalizations. Its cost-effectiveness too is supported by some studies
Surgical treatment of mitral regurgitation (MR) has evolved from mitral valve replacement (MVR) to r...
Mitral regurgitation (MR) is a common disease in developed countries, affecting an estimated 9.3% of...
Mitral regurgitation (MR) is a common disease in developed countries, affecting an estimated 9.3% of...
Mitral valve regurgitation (MR) is an important clinical issue as MR represents >30% of native valve...
Mitral regurgitation is the second most common valvular disease. The etiology is either primary or f...
Mitral regurgitation (MR) is the most prevalent valvular heart disease (VHD) and represents an impor...
Mitral regurgitation (MR) is the most prevalent valvular heart disease (VHD) and represents an impor...
Mitral regurgitation (MR) is the second most common heart valve disease worldwide and the current go...
Mitral regurgitation (MR) is the second most common heart valve disease worldwide and the current go...
Mitral regurgitation (MR) is the second most common heart valve disease worldwide and the current go...
Mitral regurgitation (MR) is the second most common heart valve disease worldwide and the current go...
Percutaneous therapy has emerged as an option for treatment of mitral regurgitation for selected, pr...
J Trent Magruder,1 Todd C Crawford,1 Joshua C Grimm,1 Joseph L Fredi,2 Ashish S Shah3 1Division of C...
Mitral regurgitation is a highly prevalent condition among elderly patients, affecting almost 10% of...
ObjectiveThe study objective was to report the midterm outcomes of MitraClip implantation in inopera...
Surgical treatment of mitral regurgitation (MR) has evolved from mitral valve replacement (MVR) to r...
Mitral regurgitation (MR) is a common disease in developed countries, affecting an estimated 9.3% of...
Mitral regurgitation (MR) is a common disease in developed countries, affecting an estimated 9.3% of...
Mitral valve regurgitation (MR) is an important clinical issue as MR represents >30% of native valve...
Mitral regurgitation is the second most common valvular disease. The etiology is either primary or f...
Mitral regurgitation (MR) is the most prevalent valvular heart disease (VHD) and represents an impor...
Mitral regurgitation (MR) is the most prevalent valvular heart disease (VHD) and represents an impor...
Mitral regurgitation (MR) is the second most common heart valve disease worldwide and the current go...
Mitral regurgitation (MR) is the second most common heart valve disease worldwide and the current go...
Mitral regurgitation (MR) is the second most common heart valve disease worldwide and the current go...
Mitral regurgitation (MR) is the second most common heart valve disease worldwide and the current go...
Percutaneous therapy has emerged as an option for treatment of mitral regurgitation for selected, pr...
J Trent Magruder,1 Todd C Crawford,1 Joshua C Grimm,1 Joseph L Fredi,2 Ashish S Shah3 1Division of C...
Mitral regurgitation is a highly prevalent condition among elderly patients, affecting almost 10% of...
ObjectiveThe study objective was to report the midterm outcomes of MitraClip implantation in inopera...
Surgical treatment of mitral regurgitation (MR) has evolved from mitral valve replacement (MVR) to r...
Mitral regurgitation (MR) is a common disease in developed countries, affecting an estimated 9.3% of...
Mitral regurgitation (MR) is a common disease in developed countries, affecting an estimated 9.3% of...